| Old Articles: <Older 39501-39510 Newer> |
|---|
 |
The Motley Fool
December 16, 2009
Eric Jhonsa |
Why This Time Is Different for Intel (Kind of) The FTC's complaints about Intel's compiler software and chipset licensing could give competitors a boost.   |
The Motley Fool
December 16, 2009
Rich Duprey |
6 Stocks Better Than China The China growth story remains popular, but you can still find great investments closer to home. |
The Motley Fool
December 16, 2009
Alyce Lomax |
5 Golden Retailers Go for the gold, lest you end up with a coal-filled stocking. As consumers scour the aisles in search of bargain-basement deals, retailers struggle to preserve their dwindling margins amid an all-out price war. |
The Motley Fool
December 16, 2009
Rick Aristotle Munarriz |
Panhandling for Papers Newspapers are turning to virtual tip jars to stay afloat. Oh no! |
The Motley Fool
December 16, 2009
Selena Maranjian |
IBM's Debt: Disaster, or No Big Deal? Corporate debt can tell you a lot about a company's prospects. |
The Motley Fool
December 16, 2009
Toby Shute |
3 Small-Cap Oil & Gas Stocks on the Move A peek at some of this week's overlooked oil patch stories from Mariner Energy, Brigham Exploration & Production, and Carrizo Oil & Gas. |
The Motley Fool
December 16, 2009
Brian Orelli |
No Holiday Goodwill Twixt Biogen and Facet Biogen and Facet are still at it, as their nasty takeover fight continues. |
The Motley Fool
December 16, 2009
Anders Bylund |
Why Comcast Pulls You Off the Couch Today Comcast is planning way ahead, and might even make it through the next entertainment revolution. |
The Motley Fool
December 16, 2009
Anders Bylund |
Adobe Defies the Recession Adobe can pin this loss on Uncle Sam, and I don't think he'll be back for more. |
The Motley Fool
December 16, 2009
Brian Orelli |
Gilead's Phase 3 Train Wreck Gilead Sciences' darusentan looked so promising. |
| <Older 39501-39510 Newer> Return to current articles. |
